Latest News about ABBV
Recent news which mentions ABBV
3 Dividend Aristocrats In Warren Buffett's Secret Portfolio You Can Buy Right Now
September 25, 2022
From Motley Fool
Is AbbVie a Buy?
September 24, 2022
From Motley Fool
Biden Announces $1.5B To Combat US Overdose Epidemic, Support Recovery
September 23, 2022
From Benzinga
Got $1,000? 2 Stocks That Could Be Bargain Buys For 2022 and Beyond
September 23, 2022
From Motley Fool
Use These 3 Simple Tricks to Maximize Your Returns From AbbVie Stock
September 23, 2022
Tickers
ABBV
From Motley Fool
3 Dividend Stocks You Can Safely Hold for Decades
September 22, 2022
From Motley Fool
Do Back-to-Back Approvals Make This Biotech Stock a Buy Now?
September 22, 2022
From Motley Fool
2 Dividend Stocks to Double Up On Right Now
September 20, 2022
From Motley Fool
3 Passive-Income Stock Secrets You'll Wish You Knew Earlier
September 19, 2022
From Motley Fool
European Authority Backs AbbVie's Crohn's Disease Candidate
September 19, 2022
Tickers
ABBV
From Benzinga
4 Strategies to Try if You Need Extra Cash From Your Investments
September 19, 2022
From Motley Fool
Top US Drugmakers Exploit US Patent System To Keep Generic Competition At Bay: Report
September 16, 2022
From Benzinga
7 Top-Rated Biotech Stocks to Buy for Q4
September 15, 2022
From InvestorPlace
US Department Of Health, Defense To Inject $1B To Boost Domestic Biomanufacturing
September 14, 2022
From Benzinga
AstraZeneca, Eli Lilly and Roche among pharmaceutical companies upgraded for high returns on R&D investments, analysts say
September 14, 2022
From MarketWatch
Biden Administration Pushes 'Cancer Moonshot' Initiative: Report
September 13, 2022
From Benzinga
3 No-Brainer Stocks to Buy in a Correction
September 13, 2022
From Motley Fool
3 Unstoppable Dividend Stocks to Buy in September
September 13, 2022
From Motley Fool
From InvestorPlace
2 Dividend Aristocrats to Buy for Passive Income That Could Outperform the Market
September 12, 2022
From Motley Fool
From Benzinga
7 S&P 500 Stocks to Buy With Superior Fundamentals
September 08, 2022
From InvestorPlace
Why Is Revance Therapeutics (RVNC) Stock Soaring Today?
September 08, 2022
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.